Bronchial Cuff Volume at Air-tight SealNCT01818102
CT Window Setting to Select Double-lumen Tube Size
A study testing Width 1000 HU/Level -450 HU and Width 400 HU/Level 25 HU in people with Bronchial Cuff Volume at Air-tight Seal and Intracuff Cuff Pressure at Air-tighe Seal, run by Seoul National University Hospital at 1 site in South Korea.
Trial summary
The purpose of this study is to investigate the appropriate window setting of chest computed tomography to select a correct size of double-lumen endobronchial tube. Read more about this study
- Who is it for?
- Ages 20 to 85 years
- Conditions the study is for
- Bronchial Cuff Volume at Air-tight Seal, Intracuff Cuff Pressure at Air-tighe Seal
- What is being tested?
- Width 1000 HU/Level -450 HU and Width 400 HU/Level 25 HU
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 228 participants
- Where
- 1 siteSouth Korea
- Study dates
- Feb 2013to Feb 2014
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 85 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients undergoing thoracic surgery that require the placement of left-sided double-lumen tubes
Who cannot join
- Abnoraml anatomy of tracheobronchail tree
- Intraluminal lesion in the left mainstem bronchus
- Anticipated difficult intubation
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study is to investigate the appropriate window setting of chest computed tomography to select a correct size of double-lumen endobronchial tube.
- Being tested
- Width 1000 HU/Level -450 HU, Width 400 HU/Level 25 HU
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Width 1000 HU/Level -450 HUDevice
Double-lumen tube size is selected according to the internal diameter of the left mainstem bronchus measured in the chest computed tomography with width 1000 HU and level -450 HU.
Width 400 HU/Level 25 HUDevice
Double-lumen tube size is selected according to the internal diameter of the left mainstem bronchus measured in the chest computed tomography with width 400 HU and level 25 HU.
| Study group | Role | What they receive |
|---|---|---|
| Width 1000 HU/Level -450 HU | Experimental | Not described Receives: Device: Width 1000 HU/Level -450 HU |
| Width 400 HU/Level 25 HU | Active comparator | Not described Receives: Device: Width 400 HU/Level 25 HU |
What is being measured
The primary outcome is the main question the study is designed to answer.
Air-leak at deflation of bronchial cuff
Measured: An expected average of 10 min after double lumen tube intubation
Air-tight seal below resting volume of bronchial cuff
Measured: An expected average of 10 min after double lumen tube intubation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Mar 2013 (estimated)
- Study startFeb 2013
- Primary completionFeb 2014
- Study completionFeb 2014
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Bronchial Cuff Volume at Air-tight SealStudies of the same condition, open and under way.
- More trials run by Seoul National University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 228 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Seoul National University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jae-Hyon Bahk, MD, PhD, Seoul National University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01818102
- Sponsor's protocol ID
- JHBahk_DLT_CT window
- Status last verified
- May 2015
- First submitted
- 18 Mar 2013
- Last updated
- 22 May 2015
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 May 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- CT Window Setting to Select Double-lumen Tube Size
- ClinicalTrials.gov ID
- NCT01818102
- Acronym / sponsor ID
- JHBahk_DLT_CT window
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 228 participants (estimated)
- Lead sponsor
- Seoul National University HospitalUniversity, hospital or other
- Study start
- Feb 2013
- Primary completion
- Feb 2014 (actual)
- Study completion
- Feb 2014 (actual)
- First posted
- 26 Mar 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to investigate the appropriate window setting of chest computed tomography to select a correct size of double-lumen endobronchial tube.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Width 1000 HU/Level -450 HU | Experimental | Device: Width 1000 HU/Level -450 HU |
| Width 400 HU/Level 25 HU | Active comparator | Device: Width 400 HU/Level 25 HU |
Who may qualify
- Ages
- 20 to 85 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Patients undergoing thoracic surgery that require the placement of left-sided double-lumen tubes
Key exclusion criteria (3 listed)
- Abnoraml anatomy of tracheobronchail tree
- Intraluminal lesion in the left mainstem bronchus
- Anticipated difficult intubation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Width 1000 HU/Level -450 HUDouble-lumen tube size is selected according to the internal diameter of the left mainstem bronchus measured in the chest computed tomography with width 1000 HU and level -450 HU. | Device | Width 1000 HU/Level -450 HU |
| Width 400 HU/Level 25 HUDouble-lumen tube size is selected according to the internal diameter of the left mainstem bronchus measured in the chest computed tomography with width 400 HU and level 25 HU. | Device | Width 400 HU/Level 25 HU |
Primary outcome
Air-leak at deflation of bronchial cuff
Time frame: An expected average of 10 min after double lumen tube intubation
Air-tight seal below resting volume of bronchial cuff
Time frame: An expected average of 10 min after double lumen tube intubation
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 May 2015.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Width 1000 HU/Level -450 HU and Width 400 HU/Level 25 HU in people with Bronchial Cuff Volume at Air-tight Seal and Intracuff Cuff Pressure at Air-tighe Seal, run by Seoul National University Hospital at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 May 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Air-leak at deflation of bronchial cuff (time frame: An expected average of 10 min after double lumen tube intubation). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2015.